Profile | GDS2987 / GI_8922674-S |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | 12.1 | 40 |
GSM215244 | HMVEC_vehicle_rep2 | ||
GSM215253 | HMVEC_vehicle_rep3 | 0.7 | 2 |
GSM215254 | HMVEC_atorvastatin_rep1 | 3.9 | 11 |
GSM215282 | HMVEC_atorvastatin_rep3 | 1.2 | 3 |
GSM215344 | HMVEC_atorvastatin_rep2 | ||
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | ||
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | 21 | 40 |
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | 12 | 20 |
GSM215294 | HMVEC_SLx2119_rep1 | ||
GSM215295 | HMVEC_SLx2119_rep2 | ||
GSM215296 | HMVEC_SLx2119_rep3 | ||
GSM215297 | PASMC_vehicle_rep1 | 296.6 | 84 |
GSM215298 | PASMC_vehicle_rep2 | 246.5 | 83 |
GSM215310 | PASMC_vehicle_rep3 | 213.4 | 82 |
GSM215311 | PASMC_atorvastatin_rep1 | 266.4 | 84 |
GSM215312 | PASMC_atorvastatin_rep2 | 260.3 | 84 |
GSM215313 | PASMC_atorvastatin_rep3 | 302.7 | 84 |
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | 272.6 | 84 |
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | 240.1 | 82 |
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | 254.2 | 83 |
GSM215327 | PASMC_SLx2119_rep1 | 240 | 83 |
GSM215328 | PASMC_SLx2119_rep2 | 178.4 | 80 |
GSM215329 | PASMC_SLx2119_rep3 | 218.3 | 82 |
GSM215330 | Fibroblasts_vehicle_rep1 | 19.2 | 41 |
GSM215331 | Fibroblasts_vehicle_rep2 | 8.3 | 24 |
GSM215332 | Fibroblasts_vehicle_rep3 | 6.2 | 21 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | 23.5 | 52 |
GSM215334 | Fibroblasts_atorvastatin_rep2 | 13.9 | 37 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | 23.9 | 50 |
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 5 | 17 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 17.1 | 48 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | ||
GSM215339 | Fibroblasts_SLx2119_rep1 | 9.8 | 29 |
GSM215340 | Fibroblasts_SLx2119_rep2 | 26 | 56 |
GSM215341 | Fibroblasts_SLx2119_rep3 | 14.1 | 34 |